A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor

Yutaka Hattori, W. Du, T. Yamada, Daijyu Ichikawa, S. Matsunami, Maiko Matsushita

研究成果: Article

5 引用 (Scopus)
元の言語English
記事番号e115
ジャーナルBlood Cancer Journal
3
発行部数5
DOI
出版物ステータスPublished - 2013 5

Fingerprint

Thalidomide
Chromosome Aberrations
Vascular Endothelial Growth Factor A
Cell Line
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Hematology

これを引用

@article{85aa1096d65e4eb5beabedad2b463112,
title = "A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor",
author = "Yutaka Hattori and W. Du and T. Yamada and Daijyu Ichikawa and S. Matsunami and Maiko Matsushita",
year = "2013",
month = "5",
doi = "10.1038/bcj.2013.13",
language = "English",
volume = "3",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor

AU - Hattori, Yutaka

AU - Du, W.

AU - Yamada, T.

AU - Ichikawa, Daijyu

AU - Matsunami, S.

AU - Matsushita, Maiko

PY - 2013/5

Y1 - 2013/5

UR - http://www.scopus.com/inward/record.url?scp=84878336896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878336896&partnerID=8YFLogxK

U2 - 10.1038/bcj.2013.13

DO - 10.1038/bcj.2013.13

M3 - Article

C2 - 23686003

AN - SCOPUS:84878336896

VL - 3

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 5

M1 - e115

ER -